1. Home
  2. LXRX vs KELYA Comparison

LXRX vs KELYA Comparison

Compare LXRX & KELYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • KELYA
  • Stock Information
  • Founded
  • LXRX 1995
  • KELYA 1946
  • Country
  • LXRX United States
  • KELYA United States
  • Employees
  • LXRX N/A
  • KELYA N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • KELYA Professional Services
  • Sector
  • LXRX Health Care
  • KELYA Consumer Discretionary
  • Exchange
  • LXRX Nasdaq
  • KELYA Nasdaq
  • Market Cap
  • LXRX 428.8M
  • KELYA 438.6M
  • IPO Year
  • LXRX 2000
  • KELYA N/A
  • Fundamental
  • Price
  • LXRX $1.52
  • KELYA N/A
  • Analyst Decision
  • LXRX Buy
  • KELYA Buy
  • Analyst Count
  • LXRX 5
  • KELYA 1
  • Target Price
  • LXRX $3.23
  • KELYA $25.00
  • AVG Volume (30 Days)
  • LXRX 2.6M
  • KELYA 310.6K
  • Earning Date
  • LXRX 11-11-2025
  • KELYA 11-06-2025
  • Dividend Yield
  • LXRX N/A
  • KELYA 2.32%
  • EPS Growth
  • LXRX N/A
  • KELYA N/A
  • EPS
  • LXRX N/A
  • KELYA N/A
  • Revenue
  • LXRX $58,432,000.00
  • KELYA $4,495,900,000.00
  • Revenue This Year
  • LXRX $67.21
  • KELYA $4.55
  • Revenue Next Year
  • LXRX N/A
  • KELYA $5.01
  • P/E Ratio
  • LXRX N/A
  • KELYA N/A
  • Revenue Growth
  • LXRX 1504.83
  • KELYA 0.97
  • 52 Week Low
  • LXRX $0.28
  • KELYA $10.80
  • 52 Week High
  • LXRX $2.18
  • KELYA $22.44
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 70.28
  • KELYA 37.69
  • Support Level
  • LXRX $1.28
  • KELYA $12.88
  • Resistance Level
  • LXRX $1.42
  • KELYA $13.22
  • Average True Range (ATR)
  • LXRX 0.10
  • KELYA 0.40
  • MACD
  • LXRX 0.02
  • KELYA -0.09
  • Stochastic Oscillator
  • LXRX 81.00
  • KELYA 3.43

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About KELYA Kelly Services Inc.

Kelly Services Inc is a provider of workforce solutions and consulting, and staffing services. The company's operations are divided into four business segments, namely Professional & Industrial, Science, Education, Outsourcing & Consulting Group, and International. Other than OCG, each segment delivers talent through staffing services, permanent placement, or outcome-based services. OCG segment delivers talent solutions, including managed service providers, payroll process outsourcing, recruitment process outsourcing, and talent advisory services. International also delivers RPO talent solutions within its local markets. The majority of revenue is derived from Professional & Industrial.

Share on Social Networks: